Free Trial
NASDAQ:KMTS

Kestra Medical Technologies (KMTS) Stock Price, News & Analysis

Kestra Medical Technologies logo
$16.55 -0.42 (-2.47%)
As of 04:00 PM Eastern

About Kestra Medical Technologies Stock (NASDAQ:KMTS)

Key Stats

Today's Range
$16.03
$17.16
50-Day Range
$14.75
$24.92
52-Week Range
$13.25
$26.15
Volume
174,917 shs
Average Volume
535,284 shs
Market Capitalization
$849.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.33
Consensus Rating
Moderate Buy

Company Overview

Receive KMTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kestra Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

KMTS Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

KMTS Stock Analysis - Frequently Asked Questions

Kestra Medical Technologies' stock was trading at $20.99 at the beginning of the year. Since then, KMTS stock has decreased by 21.2% and is now trading at $16.55.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) issued its earnings results on Monday, April, 14th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by $0.61.
Read the conference call transcript
.

Kestra Medical Technologies (KMTS) raised $202 million in an IPO on Thursday, March 6th 2025. The company issued 11,882,352 shares at a price of $17.00 per share.

Kestra Medical Technologies's lock-up period expires on Tuesday, September 2nd. Kestra Medical Technologies had issued 11,882,352 shares in its initial public offering on March 6th. The total size of the offering was $201,999,984 based on an initial share price of $17.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Shares of KMTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/14/2025
Today
7/25/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:KMTS
Previous Symbol
NASDAQ:KMTS
CIK
1877184
Web
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$23.00
Potential Upside/Downside
+65.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
6.72
Quick Ratio
6.72

Sales & Book Value

Annual Sales
$59.81 million
Price / Sales
14.21
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.00 per share
Price / Book
4.14

Miscellaneous

Outstanding Shares
51,350,000
Free Float
N/A
Market Cap
$849.84 million
Optionable
N/A
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:KMTS) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners